April 13, 2023
Alexion Pharmaceuticals launched a voluntary recall of its anti-C5 monoclonal antibody preparation Ultomiris HI for Intravenous Infusion 300 mg/3 mL (ravulizumab) in Japan on April 10. The recall came after the findings of results from regular monitoring tests carried out...read more